EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intranasal dexmedetomidine in termination of first trimester pregnancy of suction evacuation

Hang Shi, Duo Yang, Jie Liu

Asian Journal of Anesthesiology · 2017

DOI: 10.1016/j.aja.2017.09.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Anesthesiology, 2017. Verfasst von Hang Shi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: -adrenoreceptor agonist which provides sedation, anxiolysis and analgesia, without any of the complications associated with the popular sedatives. METHODS: A total number of 90 patients were randomized to three groups: 1. group P, treated with intranasal saline, intravenous saline and propofol; 2. group DP, treated with intranasal dexmedetomidine, intravenous saline and propofol; and 3. group SP, treated with intranasal saline, intravenous sulfentanil and propofol. The primary outcome was the consumption of propofol, and the secondary outcomes were numeric rating scale (NRS) anxiety score, NRS pain score of uterine cramping, amount of blood loss, use of oxytocin and NRS satisfaction scores of obstetric and gynecological (ob/gyn) physicians and patients. RESULTS: The consumption of propofol, NRS pain score of uterine cramping after surgery, NRS anxiety score, and amount of blood loss in group DP were significantly lower than those in group P and group SP. Ob/gyn physicians' satisfaction score in group DP was significantly higher compared with group SP and group P. CONCLUSION: Sedation with intranasal dexmedetomidine (1 μg/kg) provided effective analgesia and anxiolysis, reduced consumption of propofol and lower blood loss in termination of first trimester pregnancy of suction evacuation. Compared with propofol or the combination of propofol and sulfentanil, intranasal dexmedetomidine was associated with higher satisfaction score of ob/gyn physicians. No unforeseen perioperative respiratory and cardiovascular adverse events occurred. REGISTRY NUMBER FOR CLINICAL TRIALS: ChiCTR-IPR-14005654.

Zitieren

APA

Shi, H., Yang, D., & Liu, J. (2017). Intranasal dexmedetomidine in termination of first trimester pregnancy of suction evacuation. Asian Journal of Anesthesiology. https://doi.org/10.1016/j.aja.2017.09.001

Vancouver

Shi H, Yang D, Liu J. Intranasal dexmedetomidine in termination of first trimester pregnancy of suction evacuation. Asian Journal of Anesthesiology. 2017. doi:10.1016/j.aja.2017.09.001

BibTeX
@article{Shi2017,
  author = {Shi, Hang and Yang, Duo and Liu, Jie},
  title = {Intranasal dexmedetomidine in termination of first trimester pregnancy of suction evacuation},
  journal = {Asian Journal of Anesthesiology},
  year = {2017},
  doi = {10.1016/j.aja.2017.09.001}
}
Kostenlos starten →